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Rationale
Respiratory viruses are key in the development of
exacerbations in COPD and asthma. We sought to char-
acterise respiratory viruses to develop a model in which
airway exposure to virus in addition to chronic allergen
resulted in an exacerbated inflammatory and altered
functional phenotype.
Methods
BALB/c mice or human ICAM-1 transgenic mice
(BALB/c background) were used in all assays. Animals
were intranasally inoculated with either human rhino-
virus 1B (HRV1B), human rhinovirus 16 (HRV16) or
influenza A/Victoria/3/75 (H3N2). The kinetics of viral
replication in naive animals and the lung inflammatory
profiles in bronchoalveolar lavage (BAL) were assessed
for up to seven days after single inoculations. The
effects of HRV1B and H3N2 inoculation were further
assessed in a model of chronic lung inflammation: ani-
mals were intranasally challenged with house dust mite
extract (HDM) for up to seven weeks. Virus challenges
were given after a robust HDM allergic phenotype
developed. Some groups of animals were also treated
with fluticasone propionate during and after the viral
inoculation. After cessation of the challenge period, air-
way hyperresponsiveness (AHR) was assessed using
whole body plethysmography, followed by BAL, serum
and lung tissue analysis. In addition, the arterial oxygen
saturation (PO2) of H3N2 treated animals was tested
using pulse oximetry.
Results
In vitro cytopathic effect assays did not demonstrate that
either HRV1B or HRV16 were able to replicate in lungs
of relevant mice. After viral inoculation, a variable
inflammatory response was detectable only in HRV1B
treated animals up to 24 hours post inoculation. Ani-
mals treated with H3N2 developed a mixed inflamma-
tory lung inflammation and a PO2 profile indicative of a
viral effect on lung functionality. H3N2 also replicated
well in the mouse. Single inoculations of either HRV1B
or H3N2 were given to animals already challenged with
HDM. There was no indication that addition of HRV1B
to existing phenotype altered the HDM induced AHR or
inflammatory profile. Combination H3N2/ HDM treat-
ment resulted in an increase in BAL eosinophils and
neutrophils, but no change to steroid responsiveness nor
changes in PO2 readouts.
Conclusions
Strains of human rhinovirus are variably able to elicit
lung inflammation but not AHR changes following sin-
gle exposure to mouse hosts. H3N2 infection resulted in
viral replication and a strong inflammatory response,
cleared in 7 days following infection. We were unable to
demonstrate that rhinovirus infection resulted in an
exacerbation type response when given to allergic ani-
mals, but steroid sensitive inflammatory exacerbation
was noted in HDM/ influenza treated animals.
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